The session brought together investigators and collaborators to discuss upcoming projects and future directions related to the T1D GRS Consortium, with dedicated conversations around genetics in non-European ancestry populations and adult-onset disease
In conclusion, Semaglutide GLP-1 injections offer a compelling option for those seeking effective and safe weight loss
Tackling Drug-Resistant Infections Globally: Final Report and Recommendations
Frequently Asked Questions About Exenatide vs Liraglutide: First-Generation vs Second-Generation GLP-1 Agonists Which is better, Exenatide or Liraglutide
In the SURMOUNT-1 trial, adults treated with 15 mg of tirzepatide (Mounjaro) lost an average of 22.5% of their body weight over 72 weeks, while those on the 10 mg and 5 mg doses lost 21.4% and 16%, respectively
Zhou XP, Gimm O, Hampel H, Niemann T, Walker MJ, Eng C